Patient perspectives: understanding healthcare equity as a provider, patient, or person of color

Interactive Patient Journey: Hepatitis C

Why hepatitis C is called a "quiet killer"

Most people with hepatitis C have no symptoms until the disease has caused serious liver damage. Here’s what you need to know about hep C diagnosis.

Who is at risk for Hepatitis C?

Learn who has higher odds of contracting this viral infection.

My story: my hepatitis C journey as a black American

Pat, a hepatitis C survivor, shares her thoughts on disparity within the healthcare system.

How blood transfusions for sickle cell may have impacted hepatitis C rates among black americans

In the past, donated blood was not screened for hepatitis C, and this could have negatively impacted transfusions for sickle cell anemia.

The importance of diversity in clinical trials for hepatitis C

Diversity is important in clinical trials due to genetic, metabolic, social, economic, and cultural factors that contribute to disease outcomes.